Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats

Rotenone, a naturally occurring compound derived from the roots of tropical plants, is used as a broad-spectrum insecticide, piscicide, and pesticide. It is a classical, high-affinity mitochondrial complex I inhibitor that causes not only oxidative stress, α-synuclein phosphorylation, DJ-1 (Parkinso...

Full description

Saved in:
Bibliographic Details
Main Authors: Vandana Zaman, Denise Matzelle, Naren L. Banik, Azizul Haque
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/2/124
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588871949352960
author Vandana Zaman
Denise Matzelle
Naren L. Banik
Azizul Haque
author_facet Vandana Zaman
Denise Matzelle
Naren L. Banik
Azizul Haque
author_sort Vandana Zaman
collection DOAJ
description Rotenone, a naturally occurring compound derived from the roots of tropical plants, is used as a broad-spectrum insecticide, piscicide, and pesticide. It is a classical, high-affinity mitochondrial complex I inhibitor that causes not only oxidative stress, α-synuclein phosphorylation, DJ-1 (Parkinson’s disease protein 7) modifications, and inhibition of the ubiquitin-proteasome system but it is also widely considered an environmental contributor to Parkinson’s disease (PD). While prodromal symptoms, such as loss of smell, constipation, sleep disorder, anxiety/depression, and the loss of dopaminergic neurons in the substantia nigra of rotenone-treated animals, have been reported, alterations of metabolic hormones and hyperinsulinemia remain largely unknown and need to be investigated. Whether rotenone and its effect on metabolic peptides could be utilized as a biomarker for its toxic metabolic effects, which can cause long-term detrimental effects and ultimately lead to obesity, hyperinsulinemia, inflammation, and possibly gut–brain axis dysfunction, remains unclear. Here, we show that rotenone disrupts metabolic homeostasis, altering hormonal peptides and promoting infiltration of inflammatory T cells. Specifically, our results indicate a significant decrease in glucagon-like peptide-1 (GLP-1), C-peptide, and amylin. Interestingly, levels of several hormonal peptides related to hyperinsulinemia, such as insulin, leptin, pancreatic peptide (PP), peptide YY (PYY), and gastric inhibitory polypeptide (GIP), were significantly upregulated. Administration of rotenone to rats also increased body weight and activated macrophages and inflammatory T cells. These data strongly suggest that rotenone disrupts metabolic homeostasis, leading to obesity and hyperinsulinemia. The potential implications of these findings are vast, given that monitoring these markers in the blood could not only provide a crucial tool for assessing the extent of exposure and its relevance to obesity and inflammation but could also open new avenues for future research and potential therapeutic strategies.
format Article
id doaj-art-eb5698245adc41ebb696b7d7d1dffa29
institution Kabale University
issn 2073-4409
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-eb5698245adc41ebb696b7d7d1dffa292025-01-24T13:26:46ZengMDPI AGCells2073-44092025-01-0114212410.3390/cells14020124Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in RatsVandana Zaman0Denise Matzelle1Naren L. Banik2Azizul Haque3Ralph H. Johnson Veterans Administration Medical Center, 109 Bee Street, Charleston, SC 29401, USADepartment of Neurosurgery, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USARalph H. Johnson Veterans Administration Medical Center, 109 Bee Street, Charleston, SC 29401, USARalph H. Johnson Veterans Administration Medical Center, 109 Bee Street, Charleston, SC 29401, USARotenone, a naturally occurring compound derived from the roots of tropical plants, is used as a broad-spectrum insecticide, piscicide, and pesticide. It is a classical, high-affinity mitochondrial complex I inhibitor that causes not only oxidative stress, α-synuclein phosphorylation, DJ-1 (Parkinson’s disease protein 7) modifications, and inhibition of the ubiquitin-proteasome system but it is also widely considered an environmental contributor to Parkinson’s disease (PD). While prodromal symptoms, such as loss of smell, constipation, sleep disorder, anxiety/depression, and the loss of dopaminergic neurons in the substantia nigra of rotenone-treated animals, have been reported, alterations of metabolic hormones and hyperinsulinemia remain largely unknown and need to be investigated. Whether rotenone and its effect on metabolic peptides could be utilized as a biomarker for its toxic metabolic effects, which can cause long-term detrimental effects and ultimately lead to obesity, hyperinsulinemia, inflammation, and possibly gut–brain axis dysfunction, remains unclear. Here, we show that rotenone disrupts metabolic homeostasis, altering hormonal peptides and promoting infiltration of inflammatory T cells. Specifically, our results indicate a significant decrease in glucagon-like peptide-1 (GLP-1), C-peptide, and amylin. Interestingly, levels of several hormonal peptides related to hyperinsulinemia, such as insulin, leptin, pancreatic peptide (PP), peptide YY (PYY), and gastric inhibitory polypeptide (GIP), were significantly upregulated. Administration of rotenone to rats also increased body weight and activated macrophages and inflammatory T cells. These data strongly suggest that rotenone disrupts metabolic homeostasis, leading to obesity and hyperinsulinemia. The potential implications of these findings are vast, given that monitoring these markers in the blood could not only provide a crucial tool for assessing the extent of exposure and its relevance to obesity and inflammation but could also open new avenues for future research and potential therapeutic strategies.https://www.mdpi.com/2073-4409/14/2/124rotenonehormonal peptidesinflammationhyperinsulinemiaobesitydiabetes
spellingShingle Vandana Zaman
Denise Matzelle
Naren L. Banik
Azizul Haque
Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
Cells
rotenone
hormonal peptides
inflammation
hyperinsulinemia
obesity
diabetes
title Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
title_full Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
title_fullStr Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
title_full_unstemmed Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
title_short Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
title_sort dysregulation of metabolic peptides precedes hyperinsulinemia and inflammation following exposure to rotenone in rats
topic rotenone
hormonal peptides
inflammation
hyperinsulinemia
obesity
diabetes
url https://www.mdpi.com/2073-4409/14/2/124
work_keys_str_mv AT vandanazaman dysregulationofmetabolicpeptidesprecedeshyperinsulinemiaandinflammationfollowingexposuretorotenoneinrats
AT denisematzelle dysregulationofmetabolicpeptidesprecedeshyperinsulinemiaandinflammationfollowingexposuretorotenoneinrats
AT narenlbanik dysregulationofmetabolicpeptidesprecedeshyperinsulinemiaandinflammationfollowingexposuretorotenoneinrats
AT azizulhaque dysregulationofmetabolicpeptidesprecedeshyperinsulinemiaandinflammationfollowingexposuretorotenoneinrats